Clinical Study Results
What adverse reactions did the participants have?
The most common adverse reaction during the study was nausea.
The table below shows the adverse reactions that happened in at least 2 participants
during the study. There were other adverse reactions that happened during the study,
but those happened in fewer participants.
Most common adverse reactions during the study
Group 1 Group 2 Group 3 Group 4
Lowest dose of Middle dose of Highest dose of Placebo
MEDI0382 (Out of MEDI0382 (Out of MEDI0382 (Out of (Out of 16
15 participants) 15 participants) 15 participants) participants)
Nausea 13.3% (2) 46.7% (7) 20.0% (3) 6.3% (1)
Vomiting 20.0% (3) 20.0% (3) 20.0% (3) 0.0% (0)
Decreased appetite 0.0% (0) 20.0% (3) 13.3% (2) 0.0% (0)
Feeling unwell in general 0.0% (0) 0.0% (0) 20.0% (3) 0.0% (0)
How has this study helped patients and researchers?
This study helped researchers learn how MEDI0382 affects blood sugar and
weight in people who have type 2 diabetes, and if MEDI0382 is safe to take.
Researchers look at the results of many studies to decide which treatments work
best and are safest. This summary shows only the main results from this one study.
Other studies may provide new information or different results.
Further clinical studies with MEDI0382 are planned.
11